Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arolac
2. Carbamide, Methylergol
3. Cuvalit
4. Dopergin
5. Dopergine
6. Hydrochloride, Lisuride
7. Hydrogen Maleate, Lysuride
8. Lisuride Hydrochloride
9. Lisuride Maleate
10. Lisuride Maleate (1:1)
11. Lisuride Maleate, (8beta)-isomer
12. Lisuride Mesylate
13. Lisuride Phosphate (1:1)
14. Lisuride, (8alpha)-(+-)-isomer
15. Lysenyl
16. Lysurid
17. Lysuride Hydrogen Maleate
18. Maleate, Lisuride
19. Mesylate, Lisuride
20. Methylergol Carbamide
21. Revanil
1. Lysuride
2. 18016-80-3
3. Lisuride [inn]
4. Lisurida
5. Lisuridum
6. Lisuride Maleate
7. Lisuride (inn)
8. 140387-89-9
9. Lisuride (s)(-)
10. N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-n,n-diethylurea
11. S-(-)-lisuride
12. Chembl157138
13. E0qn3d755o
14. Chebi:51164
15. 1,1-diethyl-3-[(8alpha)-6-methyl-9,10-didehydroergolin-8-yl]urea
16. 18016-80-3 (free Base)
17. Lisuridum [inn-latin]
18. Lysuride Maleate
19. Lisurida [inn-spanish]
20. N,n-diethyl-n'-[(8alpha)-6-methyl-9,10-didehydroergolin-8-yl]urea
21. Dopergin
22. Dl-lisuride
23. 1,1-diethyl-3-((6ar,9s)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl)urea
24. 3-[(6ar,9s)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea
25. 3,3-diethyl-1-[(4s,7r)-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaen-4-yl]urea
26. Lisuride [inn:ban]
27. Einecs 241-925-1
28. Unii-e0qn3d755o
29. (+)-lisuride
30. H8g
31. Lisuride, (s)
32. Prestwick_525
33. 3-(9,10-didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea
34. Lisuride [mi]
35. Prestwick0_000106
36. Prestwick1_000106
37. Prestwick2_000106
38. Prestwick3_000106
39. Urea, N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-n,n-diethyl-
40. Gtpl43
41. Lisuride [who-dd]
42. Lopac0_000751
43. Schembl43950
44. Bspbio_000092
45. Spbio_002031
46. Bpbio1_000102
47. Dtxsid3023217
48. Dtxsid30274075
49. Hms1568e14
50. Zinc3831001
51. Bdbm50056445
52. Ccg-204836
53. Db00589
54. Ncgc00179663-02
55. Hy-12713
56. Cs-0012290
57. D08132
58. Q424446
59. 1,1-diethyl-3-(9,10-didehydro-6-methyl-8alpha-ergolinyl)urea
60. 3-(9,10-didehydro-6-methyl-8alpha-ergolinyl)-1,1-diethylurea
61. 3-(9,10-didehydro-6-methylergolin-8.alpha.-yl)-1,1-diethylurea
62. N''-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-n,n-diethylurea
| Molecular Weight | 338.4 g/mol |
|---|---|
| Molecular Formula | C20H26N4O |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 3 |
| Exact Mass | 338.21066147 g/mol |
| Monoisotopic Mass | 338.21066147 g/mol |
| Topological Polar Surface Area | 51.4 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 544 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For the management of Parkinson's Disease
There is evidence that lisuride lowers prolactin levels and, in low doses, prevents migraine attacks.
Serotonin Receptor Agonists
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
G - Genito urinary system and sex hormones
G02 - Other gynecologicals
G02C - Other gynecologicals
G02CB - Prolactine inhibitors
G02CB02 - Lisuride
N - Nervous system
N02 - Analgesics
N02C - Antimigraine preparations
N02CA - Ergot alkaloids
N02CA07 - Lisuride
Lisuride is an anti-Parkinson drug chemically related to the dopaminergic ergoline Parkinson's drugs. Lisuride binds to the 5-HT(1A) and 5-HT(2A/2C) receptors. It is also thought to bind to the dopamine receptor and to act as a dopamine agonist. Evidence has also emerged that Lisuride also binds to the Histamine H1 receptor.
ABOUT THIS PAGE
45
PharmaCompass offers a list of Lisuride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lisuride manufacturer or Lisuride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lisuride manufacturer or Lisuride supplier.
PharmaCompass also assists you with knowing the Lisuride API Price utilized in the formulation of products. Lisuride API Price is not always fixed or binding as the Lisuride Price is obtained through a variety of data sources. The Lisuride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lisuride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lisuride, including repackagers and relabelers. The FDA regulates Lisuride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lisuride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lisuride supplier is an individual or a company that provides Lisuride active pharmaceutical ingredient (API) or Lisuride finished formulations upon request. The Lisuride suppliers may include Lisuride API manufacturers, exporters, distributors and traders.
click here to find a list of Lisuride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lisuride DMF (Drug Master File) is a document detailing the whole manufacturing process of Lisuride active pharmaceutical ingredient (API) in detail. Different forms of Lisuride DMFs exist exist since differing nations have different regulations, such as Lisuride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lisuride DMF submitted to regulatory agencies in the US is known as a USDMF. Lisuride USDMF includes data on Lisuride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lisuride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lisuride suppliers with USDMF on PharmaCompass.
Lisuride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lisuride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lisuride GMP manufacturer or Lisuride GMP API supplier for your needs.
A Lisuride CoA (Certificate of Analysis) is a formal document that attests to Lisuride's compliance with Lisuride specifications and serves as a tool for batch-level quality control.
Lisuride CoA mostly includes findings from lab analyses of a specific batch. For each Lisuride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lisuride may be tested according to a variety of international standards, such as European Pharmacopoeia (Lisuride EP), Lisuride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lisuride USP).
